Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV™. EndoTool IV is part of the EndoTool platform, a market-leading suite of blood glucose management software solutions recognized for the ability to provide unsurpassed patient-specific glycemic control across a broad population of patients. The latest system incorporates new functionality that improves treatment by allowing for an unparalleled level of customization of insulin dosing in individual patients.
Help employers find you! Check out all the jobs and post your resume.
